Khangembam Jitenkumar Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Khangembam Jitenkumar Singh has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Saurabh Sharma
Descriptive Research Division, Indian Council of Medical Research, New Delhi, India
5 shared publications - Anjali Shetty
Microbiology Section, Department of Laboratory Medicine, P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India
4 shared publications - Gagandeep Singh
Department of Microbiology, All India Institute of Medical Sciences , New Delhi
4 shared publications - Immaculata Xess
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India
4 shared publications - Jayanthi Savio
St John’s Medical College Hospital
4 shared publications - Prashant Gupta
Department of Microbiology, King George's Medical University, Lucknow, IND
4 shared publications
Latest Publications
- Open Access
- 20 March 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
Efficacy and safety of Punarnavadi Mandura alone and in combination with Drakshavaleha compared to iron folic acid in the treatment of moderate iron deficiency anaemia among non-pregnant women of reproductive age group: a protocol for community-based three arm multicentre randomized controlled trial. (Preprint)
- 20 March 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
Open AccessEfficacy and safety of Punarnavadi Mandura alone and in combination with Drakshavaleha compared to iron folic acid in the treatment of moderate iron deficiency anaemia among non-pregnant women of reproductive age group: a protocol for community-based three arm multicentre randomized controlled trial. (Preprint)
- Open Access
- 31 May 2025
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 14 (5) , 1757-1768
Non coverage of Hepatitis B immunization among children and its predictors in northeastern states of India: A multiscale geographically weighted regression analysis
Background: Hepatitis B, a viral infection, is a vaccine-preventable disease and is a significant public health challenge globally. Child immunization is a safe and effective way to prevent Hepatitis B virus infection. The Universal Immunization Programme (UIP) of India, which effectively reduces the chronic burden, aims to reach immunization of nearly 2.67 crore newborns annually. Under this program, the Hepatitis B vaccine was introduced in 2007–2008. This study aims to assess the level and trend and identify spatial hotspots of noncoverage of Hepatitis B immunization and its predictors in northeastern states of India. Methods: This study used cross-sectional survey data from the National Family Health Survey-5 (2019–21) of 6380 children aged 12–23 months in northeastern states. We used Moran’s I and Getis-Ord Gi* statistics to investigate spatial autocorrelation and hotspots of noncoverage of Hepatitis B immunization. Additionally, we applied Multiscale Geographically Weighted Regression (MGWR) to assess its predictors for noncoverage of Hepatitis B immunization. Results: Spatial hotspot analysis results showed that noncoverage of Hepatitis B immunization was found in most of the districts in Nagaland, Manipur, Eastern and Central regions in Meghalaya, Cachar valley districts and the lower part in Assam, and a few districts in Arunachal Pradesh. Besides, MGWR results indicated that the proportion of the poorest wealth index, children of higher birth order, mothers with no media exposure, and those seeking care from private healthcare facilities were significant predictors for noncoverage of Hepatitis B immunization. Conclusion: Noncoverage of Hepatitis B immunization highlighted the clustered levels in northeastern states of India. This study provides valuable insights for policymakers and stakeholders in designing community-specific interventions, formulating policies, and conducting epidemiological research.
- 31 May 2025
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 14 (5) , 1757-1768
Open AccessNon coverage of Hepatitis B immunization among children and its predictors in northeastern states of India: A multiscale geographically weighted regression analysis
Background: Hepatitis B, a viral infection, is a vaccine-preventable disease and is a significant public health challenge globally. Child immunization is a safe and effective way to prevent Hepatitis B virus infection. The Universal Immunization Programme (UIP) of India, which effectively reduces the chronic burden, aims to reach immunization of nearly 2.67 crore newborns annually. Under this program, the Hepatitis B vaccine was introduced in 2007–2008. This study aims to assess the level and trend and identify spatial hotspots of noncoverage of Hepatitis B immunization and its predictors in northeastern states of India. Methods: This study used cross-sectional survey data from the National Family Health Survey-5 (2019–21) of 6380 children aged 12–23 months in northeastern states. We used Moran’s I and Getis-Ord Gi* statistics to investigate spatial autocorrelation and hotspots of noncoverage of Hepatitis B immunization. Additionally, we applied Multiscale Geographically Weighted Regression (MGWR) to assess its predictors for noncoverage of Hepatitis B immunization. Results: Spatial hotspot analysis results showed that noncoverage of Hepatitis B immunization was found in most of the districts in Nagaland, Manipur, Eastern and Central regions in Meghalaya, Cachar valley districts and the lower part in Assam, and a few districts in Arunachal Pradesh. Besides, MGWR results indicated that the proportion of the poorest wealth index, children of higher birth order, mothers with no media exposure, and those seeking care from private healthcare facilities were significant predictors for noncoverage of Hepatitis B immunization. Conclusion: Noncoverage of Hepatitis B immunization highlighted the clustered levels in northeastern states of India. This study provides valuable insights for policymakers and stakeholders in designing community-specific interventions, formulating policies, and conducting epidemiological research.
- Open Access
- 27 April 2025
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 47, e2025021
Geospatial analysis of neonatal mortality in north-eastern India: a multilevel Bayesian approach
OBJECTIVES: Neonatal mortality remains a significant public health issue in India. This study investigates spatial patterns and contributing factors to neonatal mortality in the north-eastern states, identifying hotspot regions and spatial variations.METHODS: A sample of 34,222 mothers from India’s National Family Health Survey (NFHS-5, 2019-21) in the north-eastern states was analysed. Descriptive and bivariate analyses were conducted alongside Bayesian multilevel logistic regression using integrated nested Laplace approximation to model neonatal mortality. Spatial hotspot analysis using Getis-Ord Gi* statistics identified clusters of high neonatal mortality, while geographically weighted regression (GWR) was used to examine spatial variations in the relationships between neonatal mortality and contributing factors.RESULTS: The neonatal mortality rate in the north-eastern states declined from 45 to 21 per 1,000 live births (NFHS-1 to NFHS-5) but remains higher than the national average. Assam reported the highest mortality (42.16%), whereas Sikkim had the lowest (0.87%). Higher mortality was observed among male infants, mothers with advanced age, low maternal education, and mothers who attended less than 5 antenatal care (ANC) visits. Spatial analysis identified hotspots in Assam, Meghalaya, and Tripura. GWR indicated that areas with less than 5 ANC visits had the strongest association with neonatal mortality. Bayesian multilevel analysis highlighted spatial variations of up to 51% across districts in northeast India.CONCLUSIONS: This study underscores spatial disparities in neonatal mortality across north-eastern India. Addressing childcare practices and healthcare access in hotspot regions is essential for improving new-born health outcomes. The findings provide critical insights for policymakers to develop targeted interventions aimed at reducing neonatal mortality in these underserved areas.
- 27 April 2025
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 47, e2025021
Open AccessGeospatial analysis of neonatal mortality in north-eastern India: a multilevel Bayesian approach
OBJECTIVES: Neonatal mortality remains a significant public health issue in India. This study investigates spatial patterns and contributing factors to neonatal mortality in the north-eastern states, identifying hotspot regions and spatial variations.METHODS: A sample of 34,222 mothers from India’s National Family Health Survey (NFHS-5, 2019-21) in the north-eastern states was analysed. Descriptive and bivariate analyses were conducted alongside Bayesian multilevel logistic regression using integrated nested Laplace approximation to model neonatal mortality. Spatial hotspot analysis using Getis-Ord Gi* statistics identified clusters of high neonatal mortality, while geographically weighted regression (GWR) was used to examine spatial variations in the relationships between neonatal mortality and contributing factors.RESULTS: The neonatal mortality rate in the north-eastern states declined from 45 to 21 per 1,000 live births (NFHS-1 to NFHS-5) but remains higher than the national average. Assam reported the highest mortality (42.16%), whereas Sikkim had the lowest (0.87%). Higher mortality was observed among male infants, mothers with advanced age, low maternal education, and mothers who attended less than 5 antenatal care (ANC) visits. Spatial analysis identified hotspots in Assam, Meghalaya, and Tripura. GWR indicated that areas with less than 5 ANC visits had the strongest association with neonatal mortality. Bayesian multilevel analysis highlighted spatial variations of up to 51% across districts in northeast India.CONCLUSIONS: This study underscores spatial disparities in neonatal mortality across north-eastern India. Addressing childcare practices and healthcare access in hotspot regions is essential for improving new-born health outcomes. The findings provide critical insights for policymakers to develop targeted interventions aimed at reducing neonatal mortality in these underserved areas.
- 13 March 2025
- Published by Springer Nature in Journal of Technology in Behavioral Science
- Vol. 10 (4) , 779-792
Classification and Feature Selection of Autism Spectrum Disorder Using MRI Data: A Machine Learning Approach
- 13 March 2025
- Published by Springer Nature in Journal of Technology in Behavioral Science
- Vol. 10 (4) , 779-792
Classification and Feature Selection of Autism Spectrum Disorder Using MRI Data: A Machine Learning Approach
- Open Access
- 4 March 2025
- Published by IntechOpen
Advancing Fungal Diagnostic and Research Stewardship in India: A Prospective Strategic 10-Step Plan for Addressing a National Public Health Challenge
Invasive fungal infections (IFIs) are silent killers, frequently undiagnosed and untreated. India faces significant challenges with limited diagnostic facilities, scarce data on fungal infection, and rising antifungal resistance. The COVID-associated mucormycosis surge highlighted the urgent need for stronger diagnostic infrastructure for fungal infections. Recognizing this, the Indian Council of Medical Research (ICMR) launched a network of mycology laboratories with advanced diagnostic capabilities across India using a 10-step plan described in this paper. Laboratories were selected using a three-pronged screening approach. Eight Advanced Mycology Diagnostic and Research Centers (AMDRCs) were set up in North, West, Central, South, South-Central, East, and Northeast zones from 2020 to 2022. Each AMDRC received ongoing support in training and quality assurance. The network features a digital data system, fungal repository, and clinical registry to track IFIs in ICU patients. In 2022–2023, the network identified 16.3% of fungal cases, mainly Candida spp. (56%, n = 5764/10293) and Aspergillus spp. (28%, n = 2882/10293), with 1.5% (n = 227/14861) IFIs and seven rare diseases (Eumycetoma and Chromoblastomycosis) reported in 2023. Candida auris showed high resistance to Amphotericin-B (61.2%, n = 30/49) and Fluconazole (57.1%, n = 28/49). The ICMR-MycoNet has significantly improved access to fungal diagnostics, enabling early detection and management. Comprehensive data on infection trends and resistance patterns provide valuable insights for targeted treatments and outbreak preparedness, strengthening public health efforts.
- 4 March 2025
- Published by IntechOpen
Open AccessAdvancing Fungal Diagnostic and Research Stewardship in India: A Prospective Strategic 10-Step Plan for Addressing a National Public Health Challenge
Invasive fungal infections (IFIs) are silent killers, frequently undiagnosed and untreated. India faces significant challenges with limited diagnostic facilities, scarce data on fungal infection, and rising antifungal resistance. The COVID-associated mucormycosis surge highlighted the urgent need for stronger diagnostic infrastructure for fungal infections. Recognizing this, the Indian Council of Medical Research (ICMR) launched a network of mycology laboratories with advanced diagnostic capabilities across India using a 10-step plan described in this paper. Laboratories were selected using a three-pronged screening approach. Eight Advanced Mycology Diagnostic and Research Centers (AMDRCs) were set up in North, West, Central, South, South-Central, East, and Northeast zones from 2020 to 2022. Each AMDRC received ongoing support in training and quality assurance. The network features a digital data system, fungal repository, and clinical registry to track IFIs in ICU patients. In 2022–2023, the network identified 16.3% of fungal cases, mainly Candida spp. (56%, n = 5764/10293) and Aspergillus spp. (28%, n = 2882/10293), with 1.5% (n = 227/14861) IFIs and seven rare diseases (Eumycetoma and Chromoblastomycosis) reported in 2023. Candida auris showed high resistance to Amphotericin-B (61.2%, n = 30/49) and Fluconazole (57.1%, n = 28/49). The ICMR-MycoNet has significantly improved access to fungal diagnostics, enabling early detection and management. Comprehensive data on infection trends and resistance patterns provide valuable insights for targeted treatments and outbreak preparedness, strengthening public health efforts.
- Open Access
- 1 March 2025
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 161 (2) , 159-166
Caesarean section delivery & determining factors in northeastern State, India: A Bayesian spatio-temporal analysis of areal data
Background & objectives: Caesarean Section (CS) is a crucial life-saving surgical procedure for maternal delivery when normal delivery is ruled out for the safety of mother and infant. This study investigated the spatio-temporal pattern of CS rates to assess the significant factors boosting this delivery in the northeastern States of India. Methods: We analysed cross-sectional data from three rounds of the National Family Health Survey (NFHS 3, NFHS 4, and NFHS 5). We estimated the relative risk (RR) of CS delivery and assessed the global and local spatial autocorrelation for each year from 2011 to 2019. Furthermore, the posterior median RR with credible interval was estimated using Bayesian Spatio-temporal modelling with Markov Chain Monte Carlo simulation. Results: The CS rates in the northeastern States have escalated by nearly 15 per cent over the last two decades, from 5.4 per cent in 2001 to 19.9 per cent in 2019. Furthermore, we observed a substantial increase in the high-high Local Indicator of Spatial Analysis clusters from 2011 to 2019. The estimated posterior median RR exceeded one for four significant predictors: maternal age, maternal education, obesity, and household wealth status. This analysis also revealed that the estimated spatio-temporal trend displayed a clear upward trend in CS risk during the nine-year study period. Interpretation & conclusions: This study found a substantial increase in CS delivery rate over the nine-year period (2011 to 2019) in the northeastern States of India. The findings of the study provide important policy input for strengthening healthcare intervention and regulations by initiating targeted programmes to monitor and avert excessive use of CS facilities in districts with high CS delivery.
- 1 March 2025
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 161 (2) , 159-166
Open AccessCaesarean section delivery & determining factors in northeastern State, India: A Bayesian spatio-temporal analysis of areal data
Background & objectives: Caesarean Section (CS) is a crucial life-saving surgical procedure for maternal delivery when normal delivery is ruled out for the safety of mother and infant. This study investigated the spatio-temporal pattern of CS rates to assess the significant factors boosting this delivery in the northeastern States of India. Methods: We analysed cross-sectional data from three rounds of the National Family Health Survey (NFHS 3, NFHS 4, and NFHS 5). We estimated the relative risk (RR) of CS delivery and assessed the global and local spatial autocorrelation for each year from 2011 to 2019. Furthermore, the posterior median RR with credible interval was estimated using Bayesian Spatio-temporal modelling with Markov Chain Monte Carlo simulation. Results: The CS rates in the northeastern States have escalated by nearly 15 per cent over the last two decades, from 5.4 per cent in 2001 to 19.9 per cent in 2019. Furthermore, we observed a substantial increase in the high-high Local Indicator of Spatial Analysis clusters from 2011 to 2019. The estimated posterior median RR exceeded one for four significant predictors: maternal age, maternal education, obesity, and household wealth status. This analysis also revealed that the estimated spatio-temporal trend displayed a clear upward trend in CS risk during the nine-year study period. Interpretation & conclusions: This study found a substantial increase in CS delivery rate over the nine-year period (2011 to 2019) in the northeastern States of India. The findings of the study provide important policy input for strengthening healthcare intervention and regulations by initiating targeted programmes to monitor and avert excessive use of CS facilities in districts with high CS delivery.
- 18 November 2024
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 457-465
Spatial Clustering of Pregnancy Wastage and its Determinants in Manipur: Evidence from National Family Health Surveys
Background Pregnancy-related deaths and complications have remained unacceptably high, particularly in low- and middle-income countries. Manipur is the most prevalent state for pregnancy wastage in India with an increasing trend over the last two decades. Aim The study aims to explore the level, pattern, spatial clustering, and determinants of pregnancy wastage in Manipur. Data and Methods We utilized the NFHS-4 (2015–2016) and NFHS-5(2019–2021) data of Manipur. The Getis-OrdGi* spatial statistical tool was used to identify the hotspots clusters. Bayesian logistic regression analysis was applied to identify the determinants of pregnancy wastage. Results The major hotspot clusters for pregnancy wastage were found in the valley districts, namely Imphal East, Imphal West, Thoubal, and Bishnupur. Further, a significant decline in hotspot clusters can be seen in the last five years. BMI was found to be a significant determinant for both abortion and miscarriage. Education, working status, number of antenatal care visits, wealth index and use of smokeless tobacco were associated with higher risks of having abortion among women. Conclusion The results highlight the need to develop district- centric antenatal care services to reduce the risk of pregnancy-related complications. Intervention should be tailored according to the life style choices and unique cultural practices of women in Manipur, India. It may also be beneficial to study the factors associated with declining hotspot clusters in some districts of Manipur.
- 18 November 2024
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 457-465
Spatial Clustering of Pregnancy Wastage and its Determinants in Manipur: Evidence from National Family Health Surveys
Background Pregnancy-related deaths and complications have remained unacceptably high, particularly in low- and middle-income countries. Manipur is the most prevalent state for pregnancy wastage in India with an increasing trend over the last two decades. Aim The study aims to explore the level, pattern, spatial clustering, and determinants of pregnancy wastage in Manipur. Data and Methods We utilized the NFHS-4 (2015–2016) and NFHS-5(2019–2021) data of Manipur. The Getis-OrdGi* spatial statistical tool was used to identify the hotspots clusters. Bayesian logistic regression analysis was applied to identify the determinants of pregnancy wastage. Results The major hotspot clusters for pregnancy wastage were found in the valley districts, namely Imphal East, Imphal West, Thoubal, and Bishnupur. Further, a significant decline in hotspot clusters can be seen in the last five years. BMI was found to be a significant determinant for both abortion and miscarriage. Education, working status, number of antenatal care visits, wealth index and use of smokeless tobacco were associated with higher risks of having abortion among women. Conclusion The results highlight the need to develop district- centric antenatal care services to reduce the risk of pregnancy-related complications. Intervention should be tailored according to the life style choices and unique cultural practices of women in Manipur, India. It may also be beneficial to study the factors associated with declining hotspot clusters in some districts of Manipur.
- Open Access
- 16 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e54672
Pan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study
Background: Fungal infections are now a great public health threat, especially in those with underlying risk factors such as neutropenia, diabetes, high-dose steroid treatment, cancer chemotherapy, prolonged intensive care unit stay, and so on, which can lead to mycoses with higher mortality rates. The rates of these infections have been steadily increasing over the past 2 decades due to the increasing population of patients who are immunocompromised. However, the data regarding the exact burden of such infection are still not available from India. Therefore, this registry was initiated to collate systematic data on invasive fungal infections (IFIs) across the country. Objective: The primary aim of this study is to create a multicenter digital clinical registry and monitor trends of IFIs and emerging fungal diseases, as well as early signals of any potential fungal outbreak in any region. The registry will also capture information on the antifungal resistance patterns and the contribution of fungal infections on overall morbidity and inpatient mortality across various conditions. Methods: This multicenter, prospective, noninterventional observational study will be conducted by the Indian Council of Medical Research through a web-based data collection method from 8 Advanced Mycology Diagnostic and Research Centers across the country. Data on age, gender, clinical signs and symptoms, date of admission, date of discharge or death, diagnostic tests performed, identified pathogen details, antifungal susceptibility testing, outcome, and so on will be obtained from hospital records. Descriptive and multivariate statistical methods will be applied to investigate clinical manifestations, risk variables, and treatment outcomes. Results: These Advanced Mycology Diagnostic and Research Centers are expected to find the hidden cases of fungal infections in the intensive care unit setting. The study will facilitate the enhancement of the precision of fungal infection diagnosis and prompt treatment modalities in response to antifungal drug sensitivity tests. This registry will improve our understanding of IFIs, support evidence-based clinical decision-making ability, and encourage public health policies and actions. Conclusions: Fungal diseases are a neglected public health problem. Fewer diagnostic facilities, scanty published data, and increased vulnerable patient groups make the situation worse. This is the first systematic clinical registry of IFIs in India. Data generated from this registry will increase our understanding related to the diagnosis, treatment, and prevention of fungal diseases in India by addressing pertinent gaps in mycology. This initiative will ensure a visible impact on public health in the country.
- 16 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e54672
Open AccessPan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study
Background: Fungal infections are now a great public health threat, especially in those with underlying risk factors such as neutropenia, diabetes, high-dose steroid treatment, cancer chemotherapy, prolonged intensive care unit stay, and so on, which can lead to mycoses with higher mortality rates. The rates of these infections have been steadily increasing over the past 2 decades due to the increasing population of patients who are immunocompromised. However, the data regarding the exact burden of such infection are still not available from India. Therefore, this registry was initiated to collate systematic data on invasive fungal infections (IFIs) across the country. Objective: The primary aim of this study is to create a multicenter digital clinical registry and monitor trends of IFIs and emerging fungal diseases, as well as early signals of any potential fungal outbreak in any region. The registry will also capture information on the antifungal resistance patterns and the contribution of fungal infections on overall morbidity and inpatient mortality across various conditions. Methods: This multicenter, prospective, noninterventional observational study will be conducted by the Indian Council of Medical Research through a web-based data collection method from 8 Advanced Mycology Diagnostic and Research Centers across the country. Data on age, gender, clinical signs and symptoms, date of admission, date of discharge or death, diagnostic tests performed, identified pathogen details, antifungal susceptibility testing, outcome, and so on will be obtained from hospital records. Descriptive and multivariate statistical methods will be applied to investigate clinical manifestations, risk variables, and treatment outcomes. Results: These Advanced Mycology Diagnostic and Research Centers are expected to find the hidden cases of fungal infections in the intensive care unit setting. The study will facilitate the enhancement of the precision of fungal infection diagnosis and prompt treatment modalities in response to antifungal drug sensitivity tests. This registry will improve our understanding of IFIs, support evidence-based clinical decision-making ability, and encourage public health policies and actions. Conclusions: Fungal diseases are a neglected public health problem. Fewer diagnostic facilities, scanty published data, and increased vulnerable patient groups make the situation worse. This is the first systematic clinical registry of IFIs in India. Data generated from this registry will increase our understanding related to the diagnosis, treatment, and prevention of fungal diseases in India by addressing pertinent gaps in mycology. This initiative will ensure a visible impact on public health in the country.
- Open Access
- 5 January 2024
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (1) , 42
The Development of a Clinical Registry Digital Database on Invasive Fungal Infections in India: Advancing Epidemiological Understanding and Patient Care
A well-structured digital database is essential for any national priority project as it can provide real-time data analysis and facilitate quick decision making. In recent times, particularly after the COVID-19 pandemic, invasive fungal infections (IFIs) have emerged as a significant public health challenge in India, affecting vulnerable population, including immunocompromised individuals. The lack of comprehensive and well-structured data on IFIs has hindered efforts to understand their true burden and optimize patient care. To address this critical knowledge gap, the ICMR has undertaken a Pan-India pioneer initiative to develop a network of Advanced Mycology Diagnostic research centres in different geographical zones of the country (ICMR-MycoNet). Under the aegis of this project, a clinical registry on IFIs in the ICUs is initiated. This process paper presents a detailed account of the steps involved in the establishment of a web-based data entering and monitoring platform to capture data electronically, ensuring robust and secure data collection and management. This system not only allows participating ICMR-MycoNet centres to enter patient information directly into the database using standardized Case Report Form (CRF) but also includes data validation checks to ensure the accuracy and completeness of entered data. It is complemented by a real-time, web-based, and adaptable data visualization platform. This registry aims to provide crucial epidemiological insights, promote evidence-based hospital infection control programs, and ultimately improve patient outcomes in the face of this formidable healthcare challenge.
- 5 January 2024
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (1) , 42
Open AccessThe Development of a Clinical Registry Digital Database on Invasive Fungal Infections in India: Advancing Epidemiological Understanding and Patient Care
A well-structured digital database is essential for any national priority project as it can provide real-time data analysis and facilitate quick decision making. In recent times, particularly after the COVID-19 pandemic, invasive fungal infections (IFIs) have emerged as a significant public health challenge in India, affecting vulnerable population, including immunocompromised individuals. The lack of comprehensive and well-structured data on IFIs has hindered efforts to understand their true burden and optimize patient care. To address this critical knowledge gap, the ICMR has undertaken a Pan-India pioneer initiative to develop a network of Advanced Mycology Diagnostic research centres in different geographical zones of the country (ICMR-MycoNet). Under the aegis of this project, a clinical registry on IFIs in the ICUs is initiated. This process paper presents a detailed account of the steps involved in the establishment of a web-based data entering and monitoring platform to capture data electronically, ensuring robust and secure data collection and management. This system not only allows participating ICMR-MycoNet centres to enter patient information directly into the database using standardized Case Report Form (CRF) but also includes data validation checks to ensure the accuracy and completeness of entered data. It is complemented by a real-time, web-based, and adaptable data visualization platform. This registry aims to provide crucial epidemiological insights, promote evidence-based hospital infection control programs, and ultimately improve patient outcomes in the face of this formidable healthcare challenge.
- Open Access
- 18 November 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Pan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study (Preprint)
BACKGROUND Fungal infections are now a great public health threat, especially in those with underlying risk factors such as neutropenia, diabetes, high-dose steroid treatment, cancer chemotherapy, prolonged intensive care unit stay, and so on, which can lead to mycoses with higher mortality rates. The rates of these infections have been steadily increasing over the past 2 decades due to the increasing population of patients who are immunocompromised. However, the data regarding the exact burden of such infection are still not available from India. Therefore, this registry was initiated to collate systematic data on invasive fungal infections (IFIs) across the country. OBJECTIVE The primary aim of this study is to create a multicenter digital clinical registry and monitor trends of IFIs and emerging fungal diseases, as well as early signals of any potential fungal outbreak in any region. The registry will also capture information on the antifungal resistance patterns and the contribution of fungal infections on overall morbidity and inpatient mortality across various conditions. METHODS This multicenter, prospective, noninterventional observational study will be conducted by the Indian Council of Medical Research through a web-based data collection method from 8 Advanced Mycology Diagnostic and Research Centers across the country. Data on age, gender, clinical signs and symptoms, date of admission, date of discharge or death, diagnostic tests performed, identified pathogen details, antifungal susceptibility testing, outcome, and so on will be obtained from hospital records. Descriptive and multivariate statistical methods will be applied to investigate clinical manifestations, risk variables, and treatment outcomes. RESULTS These Advanced Mycology Diagnostic and Research Centers are expected to find the hidden cases of fungal infections in the intensive care unit setting. The study will facilitate the enhancement of the precision of fungal infection diagnosis and prompt treatment modalities in response to antifungal drug sensitivity tests. This registry will improve our understanding of IFIs, support evidence-based clinical decision-making ability, and encourage public health policies and actions. CONCLUSIONS Fungal diseases are a neglected public health problem. Fewer diagnostic facilities, scanty published data, and increased vulnerable patient groups make the situation worse. This is the first systematic clinical registry of IFIs in India. Data generated from this registry will increase our understanding related to the diagnosis, treatment, and prevention of fungal diseases in India by addressing pertinent gaps in mycology. This initiative will ensure a visible impact on public health in the country. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/54672
- 18 November 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study (Preprint)
BACKGROUND Fungal infections are now a great public health threat, especially in those with underlying risk factors such as neutropenia, diabetes, high-dose steroid treatment, cancer chemotherapy, prolonged intensive care unit stay, and so on, which can lead to mycoses with higher mortality rates. The rates of these infections have been steadily increasing over the past 2 decades due to the increasing population of patients who are immunocompromised. However, the data regarding the exact burden of such infection are still not available from India. Therefore, this registry was initiated to collate systematic data on invasive fungal infections (IFIs) across the country. OBJECTIVE The primary aim of this study is to create a multicenter digital clinical registry and monitor trends of IFIs and emerging fungal diseases, as well as early signals of any potential fungal outbreak in any region. The registry will also capture information on the antifungal resistance patterns and the contribution of fungal infections on overall morbidity and inpatient mortality across various conditions. METHODS This multicenter, prospective, noninterventional observational study will be conducted by the Indian Council of Medical Research through a web-based data collection method from 8 Advanced Mycology Diagnostic and Research Centers across the country. Data on age, gender, clinical signs and symptoms, date of admission, date of discharge or death, diagnostic tests performed, identified pathogen details, antifungal susceptibility testing, outcome, and so on will be obtained from hospital records. Descriptive and multivariate statistical methods will be applied to investigate clinical manifestations, risk variables, and treatment outcomes. RESULTS These Advanced Mycology Diagnostic and Research Centers are expected to find the hidden cases of fungal infections in the intensive care unit setting. The study will facilitate the enhancement of the precision of fungal infection diagnosis and prompt treatment modalities in response to antifungal drug sensitivity tests. This registry will improve our understanding of IFIs, support evidence-based clinical decision-making ability, and encourage public health policies and actions. CONCLUSIONS Fungal diseases are a neglected public health problem. Fewer diagnostic facilities, scanty published data, and increased vulnerable patient groups make the situation worse. This is the first systematic clinical registry of IFIs in India. Data generated from this registry will increase our understanding related to the diagnosis, treatment, and prevention of fungal diseases in India by addressing pertinent gaps in mycology. This initiative will ensure a visible impact on public health in the country. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/54672